Health care in developing countries should be protected from privatisation News item 23 January 2013 Pages: 3 - 3
Increasing value for patients key to reform, says Harvard professor Comment 23 January 2013 Pages: 3 - 3
Medicare Part D: maintaining the spending status quo? Non-clinical study 23 January 2013 Pages: 7 - 7
Adjuvant hormonal therapy use appears to be low among insured, low-income woman with early breast cancer Clinical study 23 January 2013 Pages: 8 - 8
Findings from the MATRIX* study have shown that patients with overactive bladder (OAB) who are treated with oxybutinin transdermal system (TDS) Clinical study 23 January 2013 Pages: 8 - 8
MRSA screening/decolonisation not worth it in pregnant patients Clinical study 23 January 2013 Pages: 8 - 8
The use of certolizumab pegol improves health-related QOL (HRQOL) in patients with Crohn's disease Clinical study 23 January 2013 Pages: 10 - 10
The XELOX regime is more convenient and saves time for patients with colorectal cancer Clinical study 23 January 2013 Pages: 10 - 10
According to a new report by Decision Resources, the launch of targeted agents and the increased use of existing agents Media release 23 January 2013 Pages: 11 - 11
Roche has launched a program to improve access to Tamiflu [oseltamivir] in developing countries Media release 23 January 2013 Pages: 11 - 11